G1 Therapeutics, Inc. Quarterly Operating Margin in % from Q1 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
G1 Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q1 2021 to Q2 2024.
  • G1 Therapeutics, Inc. Operating Margin for the quarter ending June 30, 2024 was -65.1 %, a 12.9% increase year-over-year.
  • G1 Therapeutics, Inc. annual Operating Margin for 2023 was -47.9 %, a 82% increase from 2022.
  • G1 Therapeutics, Inc. annual Operating Margin for 2022 was -265 %, a 41.3% increase from 2021.
  • G1 Therapeutics, Inc. annual Operating Margin for 2021 was -453 %, a 112% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -65.1 +9.68 +12.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -27.2 +174 +86.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -47.9 +218 +82% Oct 1, 2023 Dec 31, 2023
Q3 2023 -78.9 +226 +74.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -74.8 +503 +87.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -201 +477 +70.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -265 +187 +41.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -305 +0.42 +0.14% Jul 1, 2022 Sep 30, 2022
Q2 2022 -578 -425 -279% Apr 1, 2022 Jun 30, 2022
Q1 2022 -678 -526 -347% Jan 1, 2022 Mar 31, 2022
Q4 2021 -453 Oct 1, 2021 Dec 31, 2021
Q3 2021 -305 Jul 1, 2021 Sep 30, 2021
Q2 2021 -153 Apr 1, 2021 Jun 30, 2021
Q1 2021 -152 Jan 1, 2021 Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.